Correction to: Development of a novel TLR8 agonist for cancer immunotherapy
Crossref DOI link: https://doi.org/10.1186/s43556-021-00042-3
Published Online: 2021-05-21
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Yuxun
Yang, Heping
Li, Huanping
Zhao, Shuda
Zeng, Yikun
Zhang, Panpan
Lin, Xiaoqin
Sun, Xiaoxiang
Wang, Longsheng
Fu, Guangliang
Gao, Yaqiao
Wang, Pei
Gao, Daxin
Text and Data Mining valid from 2021-05-21
Version of Record valid from 2021-05-21
Article History
First Online: 21 May 2021